Omeros | OMER - Ebit





Ebit Изменить Дата
Adma Biologics USD 53.66M 5.57M 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Cytokinetics USD -179.17M 2.05M 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Immunic USD -23.33M 2.67M 2025-12
Insmed USD -81.83M 19.48M 2026-09
Knight Therapeutics CAD 6.21M 3.27M 2025-12
MacroGenics USD -65.25M 33.36M 2026-06
Omeros USD -48.15M 7.25M 2023-09
Pacira USD 9.96M 5.33M 2026-06
Pfizer USD 4.85B 5.03B 2026-09
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
United Therapeutics USD 375.6M 49.8M 2026-06
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09